Watanabe H - Search Results

1

The range of optimal concentration and mechanisms of paclitaxel in radio-enhancement in gastrointestinal cancer cell lines.

Toiyama Y, Inoue Y, Hiro J, Ojima E, Watanabe H, Narita Y, Hosono A, Miki C, Kusunoki M. Toiyama Y, et al. Among authors: watanabe h. Cancer Chemother Pharmacol. 2007 May;59(6):733-42. doi: 10.1007/s00280-006-0327-1. Epub 2006 Sep 7. Cancer Chemother Pharmacol. 2007. PMID: 16957932

2

The optimal schedule for 5-fluorouracil radiosensitization in colon cancer cell lines.

Ojima E, Inoue Y, Watanabe H, Hiro J, Toiyama Y, Miki C, Kusunoki M. Ojima E, et al. Among authors: watanabe h. Oncol Rep. 2006 Nov;16(5):1085-91. Oncol Rep. 2006. PMID: 17016597

3

Schedule-dependent cytotoxicity of 5-fluorouracil and irinotecan in a colon cancer cell line.

Inoue Y, Miki C, Watanabe H, Hiro J, Toiyama Y, Ojima E, Yanagi H, Kusunoki M. Inoue Y, et al. Among authors: watanabe h. J Gastroenterol. 2006 Dec;41(12):1149-57. doi: 10.1007/s00535-006-1904-0. Epub 2007 Feb 6. J Gastroenterol. 2006. PMID: 17287894

4

Does preoperative chemo-radiotherapy enhance the expression of vascular endothelial growth factor in patients with rectal cancer?

Inoue Y, Ojima E, Watanabe H, Hiro J, Toiyama Y, Kobayashi M, Miki C, Kusunoki M. Inoue Y, et al. Among authors: watanabe h. Oncol Rep. 2007 Aug;18(2):369-75. Oncol Rep. 2007. PMID: 17611658

5

Genomic instability and tissue expression of angiogenic growth factors in sporadic colorectal cancer.

Inoue Y, Miki C, Watanabe H, Ojima E, Kusunoki M. Inoue Y, et al. Among authors: watanabe h. Surgery. 2006 Mar;139(3):305-11. doi: 10.1016/j.surg.2005.08.006. Surgery. 2006. PMID: 16546493

6

Irinotecan cytotoxicity does not necessarily depend on the UGT1A1 polymorphism but on fluoropyrimidine: a molecular case report.

Inoue Y, Miki C, Watanabe H, Hiro J, Toiyama Y, Ojima E, Nakatani K, Nobori T, Kusunoki M. Inoue Y, et al. Among authors: watanabe h. Oncol Rep. 2006 Nov;16(5):971-4. Oncol Rep. 2006. PMID: 17016579

7

Octreotide improved the quality of life in a child with malignant bowel obstruction caused by peritoneal dissemination of colon cancer.

Watanabe H, Inoue Y, Uchida K, Okugawa Y, Hiro J, Ojima E, Kobayashi M, Miki C, Kusunoki M. Watanabe H, et al. J Pediatr Surg. 2007 Jan;42(1):259-60. doi: 10.1016/j.jpedsurg.2006.09.025. J Pediatr Surg. 2007. PMID: 17208578

8

Alteration of the chemoresistant gene expression during chemotherapy for colon cancer: a molecular case report.

Toiyama Y, Inoue Y, Hiro J, Ojima E, Watanabe H, Miki C, Kusunoki M. Toiyama Y, et al. Among authors: watanabe h. Oncol Rep. 2008 Mar;19(3):755-9. Oncol Rep. 2008. PMID: 18288412

9

Decreased expression of monocyte chemoattractant protein-1 predicts poor prognosis following curative resection of colorectal cancer.

Watanabe H, Miki C, Okugawa Y, Toiyama Y, Inoue Y, Kusunoki M. Watanabe H, et al. Dis Colon Rectum. 2008 Dec;51(12):1800-5. doi: 10.1007/s10350-008-9380-7. Epub 2008 Jul 17. Dis Colon Rectum. 2008. PMID: 18633677 Clinical Trial.

10

Serum immunosuppressive acidic protein reflects systemic deterioration of colorectal cancer patient condition.

Toiyama Y, Miki C, Inoue Y, Okugawa Y, Koike Y, Watanabe H, Yokoe T, Hiro J, Ojima E, Tanaka K, Kusunoki M. Toiyama Y, et al. Among authors: watanabe h. J Surg Oncol. 2008 Apr 1;97(5):404-8. doi: 10.1002/jso.20966. J Surg Oncol. 2008. PMID: 18181167

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,245 results

Search Page

Filters